These reagents are required for the continuation of experiments studying t cell responses to chronic viral infections and cancer.

Ended Awarded Last action

Contract number
75N91024F00009
Awardee
Awarding agency
Obligated
$22,675

Award facts

Contract value 100% obligated
$22,675.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a BPA call to 10X Genomics, Inc. with a ceiling value of $22,675.00 on August 20, 2024, for research reagents supporting T cell response studies in chronic viral infections and cancer. Place of performance is Pleasanton, California. The call is firm fixed price with an ultimate completion date of August 19, 2025. No set-aside was used.

Quick answers

Who was awarded contract 75N91024F00009?

75N91024F00009 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on August 20, 2024.

How much is contract 75N91024F00009 worth?

The government has obligated $22,675 on 75N91024F00009.

Is contract 75N91024F00009 an order under another contract?

Yes. 75N91024F00009 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N91024F00009 competed?

The extent of competition for 75N91024F00009 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login